These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 22462679)
1. Regulated expression of pH sensing G Protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease. Russell JL; Goetsch SC; Aguilar HR; Coe H; Luo X; Liu N; van Rooij E; Frantz DE; Schneider JW ACS Chem Biol; 2012 Jun; 7(6):1077-83. PubMed ID: 22462679 [TBL] [Abstract][Full Text] [Related]
3. Coupling hippocampal neurogenesis to brain pH through proneurogenic small molecules that regulate proton sensing G protein-coupled receptors. Schneider JW; Goetsch SC; Leng X; Ludwig SM; Russell JL; Yang CP; Zhang QJ ACS Chem Neurosci; 2012 Jul; 3(7):557-68. PubMed ID: 22860225 [TBL] [Abstract][Full Text] [Related]
4. A dynamic notch injury response activates epicardium and contributes to fibrosis repair. Russell JL; Goetsch SC; Gaiano NR; Hill JA; Olson EN; Schneider JW Circ Res; 2011 Jan; 108(1):51-9. PubMed ID: 21106942 [TBL] [Abstract][Full Text] [Related]
5. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction. Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847 [TBL] [Abstract][Full Text] [Related]
6. Cardiac-specific overexpression of human stem cell factor promotes epicardial activation and arteriogenesis after myocardial infarction. Xiang FL; Liu Y; Lu X; Jones DL; Feng Q Circ Heart Fail; 2014 Sep; 7(5):831-42. PubMed ID: 25107671 [TBL] [Abstract][Full Text] [Related]
7. GPR68: An Emerging Drug Target in Cancer. Wiley SZ; Sriram K; Salmerón C; Insel PA Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696114 [TBL] [Abstract][Full Text] [Related]
16. Epicardium-derived fibroblasts in heart development and disease. Fang M; Xiang FL; Braitsch CM; Yutzey KE J Mol Cell Cardiol; 2016 Feb; 91():23-7. PubMed ID: 26718723 [TBL] [Abstract][Full Text] [Related]
17. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair. Huang CK; Dai D; Xie H; Zhu Z; Hu J; Su M; Liu M; Lu L; Shen W; Ning G; Wang J; Zhang R; Yan X Circ Res; 2020 Sep; 127(8):953-973. PubMed ID: 32600176 [TBL] [Abstract][Full Text] [Related]
18. Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes. Zhou B; Honor LB; Ma Q; Oh JH; Lin RZ; Melero-Martin JM; von Gise A; Zhou P; Hu T; He L; Wu KH; Zhang H; Zhang Y; Pu WT J Mol Cell Cardiol; 2012 Jan; 52(1):43-7. PubMed ID: 21907210 [TBL] [Abstract][Full Text] [Related]
19. Transforming Growth Factor-β Receptor III is a Potential Regulator of Ischemia-Induced Cardiomyocyte Apoptosis. Sun F; Li X; Duan WQ; Tian W; Gao M; Yang J; Wu XY; Huang D; Xia W; Han YN; Wang JX; Liu YX; Dong CJ; Zhao D; Ban T; Chu WF J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28559372 [TBL] [Abstract][Full Text] [Related]
20. C-terminal variable AGES domain of Thymosin β4: the molecule's primary contribution in support of post-ischemic cardiac function and repair. Hinkel R; Ball HL; DiMaio JM; Shrivastava S; Thatcher JE; Singh AN; Sun X; Faskerti G; Olson EN; Kupatt C; Bock-Marquette I J Mol Cell Cardiol; 2015 Oct; 87():113-25. PubMed ID: 26255251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]